Feltmate CM - Search Results

1

The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease.

Goldstein DP, Garner EI, Feltmate CM, Berkowitz RS. Goldstein DP, et al. Among authors: feltmate cm. Gynecol Oncol. 2004 Dec;95(3):421-2. doi: 10.1016/j.ygyno.2004.10.022. Gynecol Oncol. 2004. PMID: 15581941 No abstract available.

2

Placental site trophoblastic tumor: a 17-year experience at the New England Trophoblastic Disease Center.

Feltmate CM, Genest DR, Wise L, Bernstein MR, Goldstein DP, Berkowitz RS. Feltmate CM, et al. Gynecol Oncol. 2001 Sep;82(3):415-9. doi: 10.1006/gyno.2001.6265. Gynecol Oncol. 2001. PMID: 11520134 Review.

3

Osteopontin as a potential diagnostic biomarker for ovarian cancer.

Kim JH, Skates SJ, Uede T, Wong KK, Schorge JO, Feltmate CM, Berkowitz RS, Cramer DW, Mok SC. Kim JH, et al. Among authors: feltmate cm. JAMA. 2002 Apr 3;287(13):1671-9. doi: 10.1001/jama.287.13.1671. JAMA. 2002. PMID: 11926891

4

Advances in the understanding of placental site trophoblastic tumor.

Feltmate CM, Genest DR, Goldstein DP, Berkowitz RS. Feltmate CM, et al. J Reprod Med. 2002 May;47(5):337-41. J Reprod Med. 2002. PMID: 12063871 Review.

5

Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation.

Feltmate CM, Batorfi J, Fulop V, Goldstein DP, Doszpod J, Berkowitz RS. Feltmate CM, et al. Obstet Gynecol. 2003 Apr;101(4):732-6. doi: 10.1016/s0029-7844(03)00009-7. Obstet Gynecol. 2003. PMID: 12681878

6

Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy.

Wolfberg AJ, Feltmate C, Goldstein DP, Berkowitz RS, Lieberman E. Wolfberg AJ, et al. Obstet Gynecol. 2004 Sep;104(3):551-4. doi: 10.1097/01.AOG.0000136099.21216.45. Obstet Gynecol. 2004. PMID: 15339768

7

Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.

Wolfberg AJ, Berkowitz RS, Goldstein DP, Feltmate C, Lieberman E. Wolfberg AJ, et al. Obstet Gynecol. 2005 Sep;106(3):548-52. doi: 10.1097/01.AOG.0000174583.51617.25. Obstet Gynecol. 2005. PMID: 16135585

8

The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey.

Garner EI, Feltmate CM, Goldstein DP, Berkowitz RS. Garner EI, et al. Among authors: feltmate cm. Gynecol Oncol. 2005 Oct;99(1):3-5. doi: 10.1016/j.ygyno.2005.08.001. Gynecol Oncol. 2005. PMID: 16139344 No abstract available.

9

Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal carcinomas.

Feltmate CM, Lee KR, Johnson M, Schorge JO, Wong KK, Hao K, Welch WR, Bell DA, Berkowitz RS, Mok SC. Feltmate CM, et al. Clin Cancer Res. 2005 Nov 1;11(21):7651-7. doi: 10.1158/1078-0432.CCR-05-1008. Clin Cancer Res. 2005. PMID: 16278384

10

Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance.

Wamunyokoli FW, Bonome T, Lee JY, Feltmate CM, Welch WR, Radonovich M, Pise-Masison C, Brady J, Hao K, Berkowitz RS, Mok S, Birrer MJ. Wamunyokoli FW, et al. Among authors: feltmate cm. Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):690-700. doi: 10.1158/1078-0432.CCR-05-1110. Clin Cancer Res. 2006. PMID: 16467078

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters